Mosley Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$307K Sell
245
-18
-7% -$21.2K 0.09% 136
2026
Q2
$316K Sell
263
-1,248
-83% -$1.28M 0.1% 131
2026
Q1
$1.15M Buy
1,511
+19
+1% +$19.3K 0.52% 42
2025
Q4
$1.26M Buy
+1,492
New +$1.43M 0.58% 40
2024
Q4
$983K Buy
1,223
+160
+15% +$132K 0.61% 36
2024
Q3
$963K Buy
1,063
+155
+17% +$139K 0.66% 29
2024
Q2
$822K Sell
908
-106
-10% -$84.8K 0.7% 27
2024
Q1
$789K Sell
1,014
-37
-4% -$26.3K 0.74% 28
2023
Q4
$613K Buy
+1,051
New +$613K 0.6% 34

Other funds holding LLY

Mosley Wealth Management's LLY Position: Q3 2026 in Review

Mosley Wealth Management reduced its Eli Lilly (LLY) stake by 6.8% in Q3 2026, selling an estimated $21.2K and leaving 245 shares worth $307K. The position accounts for 0.09% of the portfolio, ranked #136.

Mosley Wealth Management first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.26M in Q4 2025. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Mosley Wealth Management held 245 shares of Eli Lilly worth $307K as of Q3 2026.
  • Mosley Wealth Management sold 18 Eli Lilly shares in Q3 2026, an estimated $21.2K.
  • Eli Lilly made up 0.09% of Mosley Wealth Management's portfolio in Q3 2026, its #136 holding.
  • Mosley Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • Mosley Wealth Management's Eli Lilly position peaked at $1.26M in Q4 2025.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Mosley Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.